Testing effectiveness (Phase 2)Study completedNCT05478239What this trial is testingArtemiCoffee in Patients With Rising PSAWho this might be right forProstate Cancer Zin W Myint 20
Testing effectiveness (Phase 2)Study completedNCT03315871What this trial is testingCombination Immunotherapy in Biochemically Recurrent Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Looking for participantsNCT05946824What this trial is testingThis Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.Who this might be right forRecurrent Prostate Cancer After Surgery University of Rochester 80
Testing effectiveness (Phase 2)Study completedNCT04733768What this trial is testing18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate CancerWho this might be right forProstate Cancer University of Alberta 100
Testing effectiveness (Phase 2)Looking for participantsNCT04700332What this trial is testingPyL in Patients With High Risk and Biochemically Recurrent Prostate CancerWho this might be right forProstate Cancer Hoag Memorial Hospital Presbyterian 184
Testing effectiveness (Phase 2)Study completedNCT00908141What this trial is testingGM-CSF in Treating Patients With Relapsed Prostate CancerWho this might be right forProstate Cancer Case Comprehensive Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT00779402What this trial is testingPROvenge Treatment and Early Cancer TreatmentWho this might be right forProstate Cancer Dendreon 176
Large-scale testing (Phase 3)Active Not RecruitingNCT05794906What this trial is testingCompare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local TherapiesWho this might be right forBiochemically Recurrent Prostate Cancer Bayer 985
Testing effectiveness (Phase 2)Study completedNCT00499408What this trial is testingVitamin D and Soy Supplements in Treating Patients With Recurrent Prostate CancerWho this might be right forProstate Cancer Wake Forest University Health Sciences 26
Large-scale testing (Phase 3)UnknownNCT05847348What this trial is testing68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese PatientsWho this might be right forBiochemical Recurrence of Malignant Neoplasm of ProstateProstate CancerBCR Prostate Carcinoma Telix Pharmaceuticals (Innovations) Pty Limited 110
Early research (Phase 1)Ended earlyNCT00313534What this trial is testingNordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate CancerWho this might be right forProstate Cancer University of California, San Francisco 15
Testing effectiveness (Phase 2)Study completedNCT04019964What this trial is testingNivolumab in Biochemically Recurrent dMMR Prostate CancerWho this might be right forProstate CancerRecurrent Prostate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04206319What this trial is testingRadium-223 in Biochemically Recurrent Prostate CancerWho this might be right forBiochemical Recurrent Prostate Cancer National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047135What this trial is testingOlaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker AnalysisWho this might be right forProstate Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Testing effectiveness (Phase 2)Ended earlyNCT04336943What this trial is testingDurvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen LoadWho this might be right forBiochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma University of Washington 6
Very early researchLooking for participantsNCT06813898What this trial is testingAn Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN TrialWho this might be right forBiochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma Northwestern University 27
Testing effectiveness (Phase 2)Study completedNCT04050215What this trial is testing68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate CancerWho this might be right forBiochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate Adenocarcinoma+6 more Jonsson Comprehensive Cancer Center 937
Not applicableStudy completedNCT04447703What this trial is testingTechnology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET StudyWho this might be right forBiochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaStage IIIB Prostate Cancer AJCC v8+2 more Thomas Jefferson University 346
Large-scale testing (Phase 3)Looking for participantsNCT07831824What this trial is testingDose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])Who this might be right forProstate Cancer Lantheus Medical Imaging 408
Large-scale testing (Phase 3)Active Not RecruitingNCT06205316What this trial is testingSBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate AdenocarcinomaWho this might be right forBiochemically Recurrent Prostate CarcinomaOligometastatic Prostate CarcinomaRecurrent Prostate Adenocarcinoma+4 more Mayo Clinic 118